{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T04:16:58Z","timestamp":1743567418399,"version":"3.40.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-025-01086-3","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T07:24:27Z","timestamp":1743405867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: novel NFKB2 variant associated with pediatric eosinophilic granulomatosis with polyangiitis (EGPA) in the COVID-19 pandemic"],"prefix":"10.1186","volume":"23","author":[{"given":"Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"issue":"6","key":"1086_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","volume":"19","author":"G Emmi","year":"2023","unstructured":"Emmi G, Bettiol A, Gelain E, Bajema IM, Berti A, Burns S, et al. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol. 2023;19(6):378\u201393.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"1086_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3899\/jrheum.120808","volume":"40","author":"S Gendelman","year":"2013","unstructured":"Gendelman S, Zeft A, Spalding SJ. Childhood-onset Eosinophilic Granulomatosis with Polyangiitis (formerly Churg-Strauss Syndrome): a contemporary single-center cohort. J Rheumatol. 2013;40(6):929\u201335.","journal-title":"J Rheumatol"},{"issue":"1","key":"1086_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103219","volume":"22","author":"J White","year":"2023","unstructured":"White J, Dubey S. Eosinophilic granulomatosis with polyangiitis: A review. Autoimmun Rev. 2023;22(1): 103219.","journal-title":"Autoimmun Rev"},{"issue":"04","key":"1086_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1055\/s-0038-1669454","volume":"39","author":"Y Nguyen","year":"2018","unstructured":"Nguyen Y, Guillevin L. Eosinophilic Granulomatosis with Polyangiitis (Churg\u2013Strauss). Semin Respir Crit Care Med. 2018;39(04):471\u201381.","journal-title":"Semin Respir Crit Care Med"},{"issue":"8","key":"1086_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s40265-018-0920-8","volume":"78","author":"L Raffray","year":"2018","unstructured":"Raffray L, Guillevin L. Treatment of eosinophilic granulomatosis with polyangiitis: a review. Drugs. 2018;78(8):809\u201321.","journal-title":"Drugs"},{"issue":"3","key":"1086_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/ppul.26249","volume":"58","author":"L Ozola","year":"2023","unstructured":"Ozola L, Aleksejeva E, Stoldere D, D\u0101vidsone Z, \u0160antere R, Granti\u0146a I, et al. Mepolizumab: Therapeutic strategy for a pediatric patient with eosinophilic granulomatosis with polyangiitis. Pediatr Pulmonol. 2023;58(3):973\u20139.","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"1086_CR7","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1016\/j.jaip.2020.06.052","volume":"8","author":"J Galant-Swafford","year":"2020","unstructured":"Galant-Swafford J, Geng B, Leibel S, Akuthota P, Tucker S, Cernelc-Kohan M, et al. Two pediatric cases of ANCA-negative eosinophilic granulomatosis with polyangiitis successfully treated with dupilumab. J Allergy Clin Immunol Pract. 2020;8(10):3643-3646.e1.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"1086_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/jamadermatol.2017.5888","volume":"154","author":"MX Joseph","year":"2018","unstructured":"Joseph MX, Jenkins LE, Wechsler ME, Davis LS. Mepolizumab Treatment of Pediatric Eosinophilic Granulomatosis With Polyangiitis. JAMA Dermatol. 2018;154(4):486.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"1086_CR9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ajhg.2013.09.009","volume":"93","author":"K Chen","year":"2013","unstructured":"Chen K, Coonrod EM, Kum\u00e1novics A, Franks ZF, Durtschi JD, Margraf RL, et al. Germline mutations in NFKB2 implicate the noncanonical NF-\u03baB pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet. 2013;93(5):812\u201324.","journal-title":"Am J Hum Genet"},{"issue":"7988","key":"1086_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41586-023-06717-x","volume":"623","author":"T Le Voyer","year":"2023","unstructured":"Le Voyer T, Parent AV, Liu X, Cederholm A, Gervais A, Rosain J, et al. Autoantibodies against type I IFNs in humans with alternative NF-\u03baB pathway deficiency. Nature. 2023;623(7988):803\u201313.","journal-title":"Nature"},{"issue":"7","key":"1086_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s10875-024-01763-0","volume":"44","author":"N Fathi","year":"2024","unstructured":"Fathi N, Nirouei M, SalimianRizi Z, Fekrvand S, Abolhassani H, Salami F, et al. Clinical, Immunological, and Genetic Features in Patients with NFKB1 and NFKB2 Mutations: a Systematic Review. J Clin Immunol. 2024;44(7):160.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1086_CR12","doi-asserted-by":"publisher","first-page":"e13287","DOI":"10.1111\/jne.13287","volume":"35","author":"TT Mac","year":"2023","unstructured":"Mac TT, Castinetti F, Bar C, Julia S, Pasquet M, Romanet P, et al. Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports. J Neuroendocrinol. 2023;35(6):e13287.","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"1086_CR13","doi-asserted-by":"publisher","first-page":"e20200476","DOI":"10.1084\/jem.20200476","volume":"218","author":"RC Wirasinha","year":"2021","unstructured":"Wirasinha RC, Davies AR, Srivastava M, Sheridan JM, Sng XYX, Delmonte OM, et al. Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility. J Exp Med. 2021;218(2):e20200476.","journal-title":"J Exp Med."},{"key":"1086_CR14","doi-asserted-by":"publisher","first-page":"108325","DOI":"10.1016\/j.clim.2019.108325","volume":"211","author":"M Jariwala","year":"2020","unstructured":"Jariwala M, Laxer RM. Childhood GPA, EGPA, and MPA. Clin Immunol. 2020;211:108325.","journal-title":"Clin Immunol"},{"issue":"3","key":"1086_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","volume":"81","author":"PC Grayson","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, et al. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis. Ann Rheum Dis. 2022;81(3):309\u201314.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1086_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.jaip.2018.10.002","volume":"7","author":"A Leurs","year":"2019","unstructured":"Leurs A, Chenivesse C, Lopez B, Gibier JB, Cl\u00e9ment G, Groh M, et al. C-Reactive protein as a diagnostic tool in differential diagnosis of hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis. J Allergy Clin Immunol Pract. 2019;7(4):1347-1351.e3.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"1086_CR17","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/ppul.24089","volume":"53","author":"A Fina","year":"2018","unstructured":"Fina A, Dubus JC, Tran A, Derelle J, Reix P, Fayon M, et al. Eosinophilic granulomatosis with polyangiitis in children: Data from the French RespiRare\u00ae cohort. Pediatr Pulmonol. 2018;53(12):1640\u201350.","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"1086_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.semarthrit.2008.05.004","volume":"39","author":"J Zwerina","year":"2009","unstructured":"Zwerina J, Eger G, Englbrecht M, Manger B, Schett G. Churg-strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients. Semin Arthritis Rheum. 2009;39(2):108\u201315.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"1086_CR19","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/rheumatology\/kew029","volume":"55","author":"D Eleftheriou","year":"2016","unstructured":"Eleftheriou D, Gale H, Pilkington C, Fenton M, Sebire NJ, Brogan PA. Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK. Rheumatol Oxf Engl. 2016;55(7):1263\u201372.","journal-title":"Rheumatol Oxf Engl"},{"issue":"162","key":"1086_CR20","doi-asserted-by":"publisher","first-page":"210123","DOI":"10.1183\/16000617.0123-2021","volume":"30","author":"S Kadura","year":"2021","unstructured":"Kadura S, Raghu G. Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review. Eur Respir Rev. 2021;30(162):210123.","journal-title":"Eur Respir Rev"},{"issue":"4","key":"1086_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s10067-022-06449-9","volume":"42","author":"S Kambhatla","year":"2023","unstructured":"Kambhatla S, Vipparthy S, Manadan AM. Rheumatic diseases associated with alveolar hemorrhage: analysis of the national inpatient sample. Clin Rheumatol. 2023;42(4):1177\u201383.","journal-title":"Clin Rheumatol"},{"key":"1086_CR22","doi-asserted-by":"crossref","unstructured":"Da G, J Z, S M, Mm O, As B, K G, et al. Immunosuppression Exposure and Risk of Infection-Related Acute Care Events in Patients With Glomerular Disease: An Observational Cohort Study. Kidney Med. 2022;4(11). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36339665\/. Cited 2024 Oct 16","DOI":"10.1016\/j.xkme.2022.100553"},{"issue":"8","key":"1086_CR23","first-page":"1473","volume":"32","author":"T Gl\u00fcck","year":"2005","unstructured":"Gl\u00fcck T, Kiefmann B, Grohmann M, Falk W, Straub RH, Sch\u00f6lmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J Rheumatol. 2005;32(8):1473\u201380.","journal-title":"J Rheumatol"},{"issue":"7","key":"1086_CR24","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859\u201366.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1086_CR25","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1136\/annrheumdis-2020-218737","volume":"81","author":"K Ansarin","year":"2022","unstructured":"Ansarin K, Taghizadieh A, Safiri S, MalekMahdavi A, Ranjbar S, Teymouri S, et al. COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs. Ann Rheum Dis. 2022;81(10):e190.","journal-title":"Ann Rheum Dis"},{"issue":"687","key":"1086_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.gene.2018.12.050","volume":"1","author":"B Xiao","year":"2019","unstructured":"Xiao B, Fang D, Liu H, Wang L, Qiu W. A novel NFKB2 mutation in a Chinese patient with DAVID syndrome. Gene. 2019;1(687):319\u201322.","journal-title":"Gene"},{"issue":"6","key":"1086_CR27","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10875-023-01491-x","volume":"43","author":"K Sundaram","year":"2023","unstructured":"Sundaram K, Ferro M, Hayman G, Ibrahim MAA. Novel NFKB2 Pathogenic Variants in Two Unrelated Patients with Common Variable Immunodeficiency. J Clin Immunol. 2023;43(6):1159\u201364.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1086_CR28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10875-020-00842-2","volume":"40","author":"HS Kuehn","year":"2020","unstructured":"Kuehn HS, Bernasconi A, Niemela JE, Almejun MB, Gallego WAF, Goel S, et al. A Nonsense N -Terminus NFKB2 Mutation Leading to Haploinsufficiency in a Patient with a Predominantly Antibody Deficiency. J Clin Immunol. 2020;40(8):1093\u2013101.","journal-title":"J Clin Immunol"},{"key":"1086_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.clim.2018.11.014","volume":"205","author":"V Lougaris","year":"2019","unstructured":"Lougaris V, Moratto D, Baronio M, Lorenzini T, Rossi S, Gazzurelli L, et al. Early B cell developmental impairment with progressive B cell deficiency in NFKB2 mutated CVID disease without autoimmunity. Clin Immunol Orlando Fla. 2019;205:153\u20135.","journal-title":"Clin Immunol Orlando Fla"},{"key":"1086_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2019.00297","volume":"10","author":"C Klemann","year":"2019","unstructured":"Klemann C, Camacho-Ordonez N, Yang L, Eskandarian Z, Rojas-Restrepo JL, Frede N, et al. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2. Front Immunol. 2019;10:297.","journal-title":"Front Immunol"},{"issue":"3","key":"1086_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s10875-019-00602-x","volume":"39","author":"CA Slade","year":"2019","unstructured":"Slade CA, McLean C, Scerri T, Giang TB, Megaloudis S, Strathmore A, et al. Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2. J Clin Immunol. 2019;39(3):324\u201335.","journal-title":"J Clin Immunol"},{"issue":"40","key":"1086_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005081","volume":"95","author":"C Shi","year":"2016","unstructured":"Shi C, Wang F, Tong A, Zhang XQ, Song HM, Liu ZY, et al. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: A case report and review of literature. Medicine (Baltimore). 2016;95(40): e5081.","journal-title":"Medicine (Baltimore)"},{"key":"1086_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.imlet.2017.12.006","volume":"194","author":"D Montin","year":"2018","unstructured":"Montin D, Licciardi F, Giorgio E, Ciolfi A, Pizzi S, Mussa A, et al. Functional evaluation of natural killer cell cytotoxic activity in NFKB2-mutated patients. Immunol Lett. 2018;194:40\u20133.","journal-title":"Immunol Lett"},{"issue":"4","key":"1086_CR34","first-page":"793","volume":"32","author":"M Bienias","year":"2021","unstructured":"Bienias M, Gabrielyan A, Geberzahn L, R\u00f6sen-Wolff A, Huebner A, Jacobsen EM, et al. More severe than CVID: Combined immunodeficiency due to a novel NFKB2 mutation. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2021;32(4):793\u20137.","journal-title":"Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol"},{"issue":"13","key":"1086_CR35","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1182\/blood-2017-05-782177","volume":"130","author":"HS Kuehn","year":"2017","unstructured":"Kuehn HS, Niemela JE, Sreedhara K, Stoddard JL, Grossman J, Wysocki CA, et al. Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype. Blood. 2017;130(13):1553\u201364.","journal-title":"Blood"},{"key":"1086_CR36","doi-asserted-by":"crossref","unstructured":"Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, et al. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med. 2020;NEJMc2031364.","DOI":"10.1056\/NEJMc2031364"},{"key":"1086_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fped.2019.00061","volume":"7","author":"K Parsons","year":"2019","unstructured":"Parsons K, Cipriano SD, Rosen LB, Browne SK, Walter JE, Stone BL, et al. Severe Facial Herpes Vegetans and Viremia in NFKB2-Deficient Common Variable Immunodeficiency. Front Pediatr. 2019;7:61.","journal-title":"Front Pediatr"},{"issue":"1","key":"1086_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s10875-024-01843-1","volume":"45","author":"A Baran","year":"2024","unstructured":"Baran A, At\u0131lganL\u00fclecio\u011flu A, Gao L, Yaz\u0131c\u0131 YY, Demirel F, Metin A, et al. A Novel Heterozygous NFKB2 Variant in a Multiplex Family with Common Variable Immune Deficiency and Autoantibodies Against Type I IFNs. J Clin Immunol. 2024;45(1):48.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1086_CR39","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jaci.2020.09.020","volume":"147","author":"RS Abraham","year":"2021","unstructured":"Abraham RS, Marshall JM, Kuehn HS, Rueda CM, Gibbs A, Guider W, et al. Severe SARS-CoV-2 disease in the context of a NF-\u03baB2 loss-of-function pathogenic variant. J Allergy Clin Immunol. 2021;147(2):532-544.e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1086_CR40","doi-asserted-by":"publisher","first-page":"AB27","DOI":"10.1016\/j.jaci.2021.12.123","volume":"149","author":"V Kwiatkowski","year":"2022","unstructured":"Kwiatkowski V, Thanaputkaiporn N, Poowuttikul P. NFKB2 Mutation in 2 Siblings with DAVID Syndrome and CVID with Variable Presentations. J Allergy Clin Immunol. 2022;149(2):AB27.","journal-title":"J Allergy Clin Immunol."},{"issue":"suppl_1","key":"1086_CR41","first-page":"i46","volume":"56","author":"FE Ospina","year":"2017","unstructured":"Ospina FE, Echeverri A, Zambrano D, Suso JP, Mart\u00ednez-Blanco J, Ca\u00f1as CA, et al. Distinguishing infections vs flares in patients with systemic lupus erythematosus. Rheumatol Oxf Engl. 2017;56(suppl_1):i46-54.","journal-title":"Rheumatol Oxf Engl."},{"issue":"8","key":"1086_CR42","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00296-021-04896-2","volume":"41","author":"B \u00d6zdemir","year":"2021","unstructured":"\u00d6zdemir B, Erden A, G\u00fcven SC, Armagan B, Apaydin H, Karakas \u00d6, et al. COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis? Rheumatol Int. 2021;41(8):1515\u201321.","journal-title":"Rheumatol Int"},{"issue":"1","key":"1086_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","volume":"83","author":"B Hellmich","year":"2024","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024;83(1):30\u201347.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1086_CR44","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.24634","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res. 2021;73(8):1088\u2013105.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"1086_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jinf.2021.01.029","volume":"82","author":"JM Peng","year":"2021","unstructured":"Peng JM, Du B, Qin HY, Wang Q, Shi Y. Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients. J Infect. 2021;82(4):22\u20137.","journal-title":"J Infect"},{"issue":"12","key":"1086_CR46","doi-asserted-by":"publisher","first-page":"950531","DOI":"10.3389\/fcimb.2022.950531","volume":"27","author":"W Deng","year":"2022","unstructured":"Deng W, Xu H, Wu Y, Li J. Diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in pediatric pneumonia. Front Cell Infect Microbiol. 2022;27(12):950531.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-025-01086-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T10:17:33Z","timestamp":1743502653000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-025-01086-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1186\/s12969-025-01086-3","relation":{},"ISSN":["1546-0096"],"issn-type":[{"type":"electronic","value":"1546-0096"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study conformed with the Declaration of Helsinki's requirements and was given permission by the Institutional Review Board\/Ethics Committee related to West China Second University Hospital, Sichuan University (2020111). Informed consent was obtained from the guardians of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The family has consented to the submission of the case report to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}